Selective activation of A3 adenosine receptors with N6-(3- iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits

Circulation Research

Volumn 80, Issue 6, 1997, Pages 800-809

  Auchampach, John A ^b   Rizvi, Ali ^b   Qiu, Yumin ^b   Tang, Xian Liang ^b   Maldonado, Claudio ^b   Teschner, Steffi ^b   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b NONE

Author keywords

adenosine receptor; ischemia reperfusion injury; myocardial infarction; myocardial stunning; protein kinase C

Indexed keywords

(3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CHELERYTHRINE; HISTAMINE; UNCLASSIFIED DRUG; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; REPERFUSION INJURY; STUNNED HEART MUSCLE; ANIMAL; BLOOD; HEART; PHYSIOLOGY;

ADENOSINE; ANIMALS; HEART; HEMODYNAMIC PROCESSES; HISTAMINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; RABBITS; RATS; RECEPTORS, PURINERGIC P1;

EID: 0030612660     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.6.800     Document Type: Article

References (59)

1. Myerhof W, Muller-Brechlin R, Richter D. Molecular cloning of a novel G protein coupled receptor expressed during rat spermatogenesis. FEBS Lett. 1991;284:155-160.
2. 3 adenosine receptor. Proc Natl Acad Sci U S A. 1992;89:7432-7436.
3. 3 adenosine receptor. Proc Natl Acad Sci U S A. 1992;90:10365-10369.
4. 3 adenosine receptor. Biochim Biophys Acta. 1993; 1179:105-107.
5. 3 adenosine receptor with a widespread tissue distribution. Mol Pharmacol. 1993;44:524-532.
6. 3 adenosine receptor from BR mastocytoma cells. FASEB J. 1995;9:A166. Abstract.
7. 3 receptors. J Pharmacol Exp Ther. 1997;280:122-128.
8. 3-adenosine receptor. Mol Pharmacol. 1994;45:1101-1111.
9. Ali H, Cunha-Melo JR, Saul WF, Beaven MA. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. J Biol Chem. 1990; 265:745-753.
10. 3 receptor is the unique adenosine receptor which facilitates of allergic mediators in mast cells. J Biol Chem. 1993;268:16887-6890.
11. 3 receptors in rat brain. Mol Pharmacol. 1995;48:1038-1045.
12. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci. 1994;15:298-306.
13. 3-selective agonists. J Med Chem. 1994;37:636-646.
14. 3-adenosine receptors: mediation of behavioral depressant effects. FEBS Lett. 1993;336:57-60.
15. 3-adenosine receptors: design of selective ligands and therapeutic responses. Drugs Future. 1995;20:689-699.
16. Olafsson B, Forman MB, Puett DW, Pou A, Cates CV, Friesinger GC, Virmani R. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation. 1987;76:1135-1145.
17. Pitarys CJ, Virmani R, Vildibill HD, Jackson EK, Fortran MB. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation. 1991;83:237-247.
18. 1-selcctive adenosine analos protects the heart against infarction. Circulation. 1992;85:659-665.
19. 6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in conscious rabbits. Cardiovasc Res. 1993;27:652-656.
20. Dorheim TA, Hoffman A, van Wylen DGL, Mentzer RM. Enhanced interstitial fluid adenosine attenuates myocardial stunning. Surgery. 1991;110:136-145.
21. 1 receptor mechanism. Am J Physiol. 1992;263:H1460-H1465.
22. 1 receptor-mediated cardioprotection in the stunned myocardium. Circulation. 1993;88:235-244.
23. 1-receptor activation on myocardial stunning in intact dogs. Circulation. 1994;90(suppl I):I-479. Abstract.
24. Sekili S, Jeroudi MO, Tang X-L, Zughaib M, Sun J-Z, Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Cur Res. 1995;76:82-94.
25. Wyatt DA, Ely SW, Lasley RD. Walsh R, Mainwaring R, Berne RM, Mentzer RM Jr. Purine-enriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function. J Thorac Cardiovasc Surg. 1989;97:771-778.
26. 1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol. 1990;22:39-47.
27. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res. 1994;28:1057-1061.
28. 3 receptor involvement. Cardiovasc Res. 1994;28:1049-1056.
29. 3 receptors. J Clin Invest. 1996;98:1773-1779.
30. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987;21:737-746.
31. Vatner SF, Braunwald E. Cardiovascular control mechanisms in the conscious state. N Engl J Med. 1975;29:970-976.
32. Triana JF, Li X-Y, Jamaluddin U, Thornby JI, Bolli R. Postischemic myocardial "stunning": identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 1991; 69:731-747.
33. Li X-Y, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious dogs and open-chest dogs. J Clin Invest. 1993; 92:1025-1041.
34. Burckhartt B, Yang X-M, Tsuchida A, Mullane KM, Downey JM, Cohen MV. Acadesine extends the window of protection afforded by ischemic preconditioning in conscious rabbits. Cardiovasc Res. 1995;29:653-657.
35. Cohen MV, Yang X-M, Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res. 1994;74:998-1004.
36. Duncker DJ, Klassen CL, Ishibashi Y, Herrlinger S, Pavek T, Bache RJ. Effect of temperature on myocardial infarct size in swine. Am J Physiol. 1996;270:H1189-H1199.
37. Bolli R, Zhu WX, Thornby JI, O'Neill PG, Roberts R. Time-course and determinants of recovery of function after reversible ischemia te conscious dogs. Am J Physiol. 1988;254:H102-H114.
38. Qiu Y, Maldonado C, Tang XL, Bolli R. Late preconditioning against myocardial stunning in conscious rabbits. Circulation. 1995;92(suppl I):I-715. Abstract.
39. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
40. Sun JZ, Tang XL, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 hr after brief ischemia in conscious pigs. J Clin Invest. 1995;95:388-403.
41. Sun JZ, Tang XL, Park SW, Qui Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-576.
42. Patel BS, Jerudi MO, O'Neill PG, Bolli R. Effect of human recombinant Superoxide dismutase on canine myocardial infarction. Am J Physiol. 1990;258:H369-H380.
43. SAS Institute. SAS/STAT User's Guide, Release 6.03 Edition. Cary, NC: SAS Institute; 1988:19-26, 123-154, 549-640.
44. 1 adenosine receptors. Naunyn Schmeidebergs Arch Pharmacol. 1988;337:687-689
45. 2 receptors in rat brain. J Pharmacol Exp Ther. 1989;251:888-893.
46. 3 receptor-mediated hypotension in the rat. Br J Pharmacol. 1995;115:945-952.
47. Doyle MP, Linden J, Duling BR. Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am J Physiol. 1994;266:H2042-H2050.
48. 3 adenosine receptor, Circ Res. 1996;78:627-634.
49. 3 receptor agonist 2-CI-IB-MECA in conscious rats. Drug Dev Res. 1996;38:144. Abstract.
50. 3 adenosine receptors. J Med Chem. 1994;37:3614-3621.
51. Schwartz LB. Mast cells: function and contents. Curr Opin Immunol. 1994;6:91-97.
52. Jolly SR, Abrams GD, Romson GD, Bailie MB, Lucchesi BR. Effects of lodoxamide on ischemic reperfused myocardium. J Cardiovasc Pharmacol. 1982;4:441-448.
53. Keller LJ, Clancy RM, Birr ML, Marboe CC Cannon PJ. Acute reoxygenation injury in the isolated heart: role of resident cardiac mast cells. Circ Res. 1988;63:1044-1052.
54. 3 adenosine receptors mediate degranulation of canine BR mastocytoma cells. Drug Dev Res. 1996;38:147. Abstract.
55. 2B receptors evoke interleukin-8 secretion in human mast cells: an enprofylline-sensitive mechanism with implications for asthma. J Clin Invest. 1995;96:1979-1986.
56. Cohen MV, Downey JM. Preconditioning during ischemia: basic mechanisms and potential clinical applications. Cardiol Rev. 1995;3:137-149.
57. 1 adenosine receptors. Circulation. 1991;84:350-356.
58. ATP channel. Circulation. 1996;94(suppl I):I-164. Abstract.
59. Rice PJ, Armstrong SC, Ganote CE. Concentration-response relationships for adenosine agonists during preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol. 1996;28:1355-1365.